Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Melanoma × Dermatologic × Clear all

Phase

Status

Sponsor Class

OTHER 1481 INDUSTRY 975 NIH 258 NETWORK 56 OTHER_GOV 29 UNKNOWN 4 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Cutaneous 3 Sezary Syndrome 2 Mycosis Fungoides 2 Keratosis, Actinic 2 Carcinoma, Squamous Cell 2 Carcinoma, Basal Cell 2 Skin Neoplasms 1 Patient Compliance 1 Neoplasm Metastasis 1 Melanoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00029900 2015-03-25

ADI-PEG in Patients With Metastatic Melanoma

FDA Office of Orphan Products Development

Phase 1 Completed

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡